Here, we explore the role of p38 in regulating skeletal muscle homeostasis, the disease process, and p38α/β targeting as an approach to treating muscular dystrophies, such as facioscapulohumeral muscular dystrophy (FSHD), that is currently undergoing clinical testing. Here, MAPK14 is linked to muscular dystrophy.